Cargando…
DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease
During chronic kidney disease (CKD), alterations in bone and mineral metabolism include increased production of the hormone fibroblast growth factor 23 (FGF23) that may contribute to cardiovascular mortality. The osteocyte protein dentin matrix protein 1 (DMP1) reduces FGF23 and enhances bone minera...
Autores principales: | Dussold, Corey, Gerber, Claire, White, Samantha, Wang, Xueyan, Qi, Lixin, Francis, Connor, Capella, Maralee, Courbon, Guillaume, Wang, Jingya, Li, Chaoyuan, Feng, Jian Q., Isakova, Tamara, Wolf, Myles, David, Valentin, Martin, Aline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483996/ https://www.ncbi.nlm.nih.gov/pubmed/31044094 http://dx.doi.org/10.1038/s41413-019-0051-1 |
Ejemplares similares
-
Calcium-dependent activation of PHEX, MEPE and DMP1 in osteocytes
por: Donmez, Baris Ozgur, et al.
Publicado: (2022) -
Osteocytic FGF23 and Its Kidney Function
por: Agoro, Rafiou, et al.
Publicado: (2020) -
Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease
por: Courbon, Guillaume, et al.
Publicado: (2021) -
Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation
por: Courbon, Guillaume, et al.
Publicado: (2023) -
Osteocyte-Specific Deletion of Fgfr1 Suppresses FGF23
por: Xiao, Zhousheng, et al.
Publicado: (2014)